Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors
作者:Richard Ducray、Peter Ballard、Bernard C. Barlaam、Mark D. Hickinson、Jason G. Kettle、Donald J. Ogilvie、Catherine B. Trigwell
DOI:10.1016/j.bmcl.2007.12.035
日期:2008.2
Novel 4-anilino-1H-pyrazolo[3,4-d]pyrimidines have been synthesized and evaluated in vitro for erbB2 and EGFR kinase inhibition. A representative compound displaying oral bioavailability in rat and dog illustrates the potential of this series to provide orally active erbB2 inhibitors. (C) 2007 Elsevier Ltd. All rights reserved.
Acyclic, polynitrile-containing, sulfoniumalkoxyethenolates and their preparation